- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 99.1M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $2.16K |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $12.93K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $309.34M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $320.92M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $107.57M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $121.81M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $128.87M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $140.44M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $262.53M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $304.49M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $89.24M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $41.24M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $455.62M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $490.69M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 108.51M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $4.88M |
| Capex | Q1 2025 · Mar 31, 2024 | $951.7K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$10.64M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.10 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.11 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $40.18M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $2.39M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $15.88M |
| Revenue | Q1 2025 · Mar 31, 2024 | $192.09M |